New guidelines emphasize non-surgical treatments for uterine fibroids

Uterine fibroids are a common condition that affects up to 80% of women in their lifetime. Nearly half of those women will experience symptoms that affect their quality of life and fertility, including severe pain and anemia.

Future of EMRs: AI-Powered, Patient-Centric, and Interoperable

Mallika Edwards, Chief Product Officer, Xsolis Imagine a world where a patient can visit any healthcare provider around the globe, and that provider has access

October 24, 2024

Study identifies common misuses of spike-in normalization

Researchers at University of California San Diego have published new guidelines that could help scientists significantly improve their results when quantifying the interactions between DNA

September 14, 2024

Bristol Myers scores another Opdivo approval, as Merck converts AA to full approval for Keytruda in MCC

Bristol Myers Squibb on Friday nabbed another approval for its blockbuster cancer treatment Opdivo. The drug was approved to treat patients ages 12 and older

October 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.